Skip to content
MMetabolicMomsTHE MAGAZINE FOR MOTHERS ON GLP-1
Menu
Ranked #215 for moms · Grade C

Vyvron review

Here is a sentence worth more than it looks: "$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel." Price, period and renewal in one breath, which almost nothing else on this page attempts — and it means you can count thirteen charges a year rather than assuming twelve. Then go looking for the terms of use. The link works, the tab says Terms of Use, and what loads is the homepage.

$149/4 wks
Consult Medication
See plans at Vyvron
  • Independently scored
  • Verified
Compare top-rated alternatives for moms ↓
By Margaux Ellery, Editor-in-Chiefa mother on the MetabolicMoms desk, not a treating clinician

Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.

Vyvron at a glance

Semaglutide
$149 per 4 weeks
Tirzepatide
$199 per 4 weeks
Coverage
Not published
Brand-name
Compounded only

How we scored Vyvron

Each score comes out of Vyvron's published pricing, disclosures and oversight, and the six combine into the 47/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.

Pricing transparency72/100 · Weak

The headline rate obscures a plan requirement or a hidden step-up.

Family-budget value30/100 · Weak

Cost is unpredictable, premium, or hides behind a plan commitment.

Fits around motherhood52/100 · Weak

Little here is shaped around a mother's week or her life stage.

Ongoing support & titration54/100 · Weak

Support is thin once the prescription ships.

Clinical oversight & labs34/100 · Weak

Oversight and lab support fall short of the top of this roster — the review below says exactly where.

Flexibility to pause or cancel46/100 · Weak

Leaving costs you — notice windows, minimum terms or fees you don't get back.

How we verified this review

Last verified
August 2026
Confidence
medium
Primary source
vyvron.com

Verified 18 August 2026. Vyvron LLC prices compounded semaglutide at $149 and tirzepatide at $199, and prints the billing period alongside them: "per 4 weeks, billed every 4 weeks; auto-renews until you cancel". Four-week billing is thirteen charges a year, so those rates annualize to $1,937 and $2,587, and the site says both are founding prices due to return to $179 and $249. It carries a LegitScript badge and states there are no hidden fees and cancellation is available at any time. Set against that, its legal pages do not exist. Requests for /terms, /privacy, /privacy-policy and /shipping-policy each return the homepage under a legal-sounding title — 0.993 to 0.995 similarity to the homepage, close but never identical, so only a proper comparison catches it. A site that links to a terms of use and does not have one is publishing a document it does not possess. Its scarcity counter also still reads "100 of 100 founding spots left" on both products. No state list, no compounding pharmacy, and clean against the live FDA warning-letter index.

Pricing

Prices re-verified

MedicationMonthlyPlan
Compounded semaglutide$149Per 4 weeks, auto-renewing"$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel" — the founding rate. The site says the price returns to $179. Thirteen charges a year, not twelve.
Compounded tirzepatide$199Per 4 weeks, auto-renewing"$199 per 4 weeks" at the founding rate, returning to $249. Same four-week cycle, stated in the same sentence as the price.

Swipe the table to see plan details →

GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Vyvron's public disclosures at last review and change often; confirm the current number on Vyvron's own site.

What we like

  • Names the four-week cycle in the same sentence as the price
  • Says it auto-renews until canceled, rather than burying it
  • Both molecules priced separately, at $149 and $199 per four weeks
  • Names Vyvron LLC as the operator and carries a LegitScript badge
  • "No hidden fees · Cancel anytime · Provider-guided" on both products

The caveats

  • ⛔ There are no legal pages — terms, privacy and shipping links all return the homepage with a legal title on the tab
  • Thirteen charges a year means $1,937 for semaglutide, not the $1,788 a monthly reading implies
  • Both figures are founding rates the site says will rise to $179 and $249
  • "100 of 100 founding spots left" on both products — the counter has not moved
  • No states listed
  • No compounding pharmacy named

Vyvron for mothers: our verdict

Here is a sentence worth more than it looks: "$149 per 4 weeks, billed every 4 weeks; auto-renews until you cancel." Price, period and renewal in one breath, which almost nothing else on this page attempts — and it means you can count thirteen charges a year rather than assuming twelve. Then go looking for the terms of use. The link works, the tab says Terms of Use, and what loads is the homepage. It runs about $149/4 weeks — toward the affordable end of what we track.

We weigh Vyvron the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.

What Vyvron actually costs

  • Compounded semaglutide — Per 4 weeks, auto-renewing: $149/4 wks
  • Compounded tirzepatide — Per 4 weeks, auto-renewing: $199/4 wks

That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.

The medications Vyvron prescribes

Vyvron prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.

Where Vyvron fits — and where it doesn't — for mothers

Worth it if…

  • the real monthly cost is a real barrier and you want a low, predictable number.
  • you may need to move between semaglutide and tirzepatide as your body and hormones change.

Give it a miss if…

  • you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
  • you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.

Trust, safety, and oversight

Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.

A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.

The bottom line

Vyvron is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.

The bottom line for mothers

Best for: A mother who values a plainly stated billing cycle and can accept a seller with no legal documents at all.

Alternatives to Vyvron

Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.

  • CoreAge RxOur #1 pick

    The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.

    Visit CoreAge Rx
  • A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.

    Visit Gala Health
  • A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.

    Visit Sesame

Keep comparing Vyvron

Vyvron, answered

How much does Vyvron cost?
When we last checked, the cheapest ongoing compounded price at Vyvron was around $149 a month: $149 per 4 weeks for semaglutide and $199 per 4 weeks for tirzepatide. Prices here move quickly — confirm today's all-in number on their own site before signing up.
Is Vyvron safe to use while breastfeeding?
No GLP-1 has been shown to be safe in pregnancy or while nursing, whether compounded or brand-name, and the labeling advises against it. That applies to Vyvron as much as to anyone else. Time it for after weaning, and make the decision with your own clinician.
Does Vyvron offer both semaglutide and tirzepatide?
Yes — Vyvron offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
Where does Vyvron rank for mothers?
Vyvron takes 47/100 in our Editors' Rating, placing it #215. Six factors chosen for mothers feed that number, and CoreAge Rx is the one at the top of the list — see how they compare.

Pricing, states and verification reflect Vyvron's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers